Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,574 | -51,112 | -35,941 | -31,371 | -15,386 |
| Depreciation Amortization | 966 | 602 | 281 | 196 | 92 |
| Income taxes - deferred | -863 | -119 | -62 | -32 | -25 |
| Accounts receivable | -18,352 | 559 | 486 | 492 | 208 |
| Accounts payable and accrued liabilities | 1,739 | -3,528 | -3,414 | -1,547 | -707 |
| Other Working Capital | -13,623 | -7,178 | -10,185 | -9,340 | -1,857 |
| Other Operating Activity | 20,980 | 28,193 | 24,224 | 19,009 | 9,706 |
| Operating Cash Flow | $-6,579 | $-32,583 | $-24,611 | $-22,593 | $-7,969 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,092 | -1,146 | -722 | -594 | -392 |
| Net Acquisitions | N/A | -11,766 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,092 | $-12,912 | $-722 | $-594 | $-392 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -159 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 228,013 | 228,004 | 228,004 | 125,239 |
| Other Financing Activity | 0 | -5,271 | -5,271 | -3,884 | -3,424 |
| Financing Cash Flow | $-159 | $222,742 | $222,733 | $224,120 | $121,815 |
| Exchange Rate Effect | -5,628 | -6,459 | -6,795 | -580 | -785 |
| Beginning Cash Position | 214,054 | 43,266 | 43,266 | 43,266 | 43,266 |
| End Cash Position | 200,596 | 214,054 | 233,871 | 243,619 | 155,935 |
| Net Cash Flow | $-13,458 | $170,788 | $190,605 | $200,353 | $112,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,579 | -32,583 | -24,611 | -22,593 | -7,969 |
| Capital Expenditure | -1,092 | -1,146 | -722 | -594 | -392 |
| Free Cash Flow | -7,671 | -33,729 | -25,333 | -23,187 | -8,361 |